What should be monitored in clients taking SSRIs for changes in behavior?

Monitoring for changes in behavior, particularly suicidal ideation, is crucial for clients taking selective serotonin reuptake inhibitors (SSRIs). This is due to the initial period of treatment when some clients may experience a worsening of symptoms or new-onset suicidal thoughts, especially in younger individuals under the age of 25. SSRIs can influence mood and cognition, sometimes leading to increased impulsivity or exacerbation of depressive symptoms as the medications begin to take effect.

While sexual dysfunction, sleep patterns, and hunger levels are also important considerations in the management of side effects related to SSRIs, they do not directly pertain to acute changes in behavior related to suicide risk. Monitoring suicidal ideation allows healthcare providers to respond quickly to any concerning shifts, ensuring that the safety and well-being of the client are prioritized during the treatment process.